A high dose of Phenylbutazone (PBZ) induces gastrointestinal ulceration in previous studies, but clinical dose of 4.4 mg/kg PBZ induces gastrointestinal ulcers is limited. Early detection of PBZ-induced gastroenteropathy will be useful for diagnosis, treatment and prevention of PBZ toxicity.